These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28857721)

  • 1. Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
    Faissner S; Mahjoub Y; Mishra M; Haupeltshofer S; Hahn JN; Gold R; Koch M; Metz LM; Ben-Hur T; Yong VW
    Mult Scler; 2018 Oct; 24(12):1543-1556. PubMed ID: 28857721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Hydroxychloroquine and Indapamide Attenuates Neurodegeneration in Models Relevant to Multiple Sclerosis.
    Brown D; Moezzi D; Dong Y; Koch M; Yong VW
    Neurotherapeutics; 2021 Jan; 18(1):387-400. PubMed ID: 33410109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective combination of minocycline and interferon-beta in a model of multiple sclerosis.
    Giuliani F; Fu SA; Metz LM; Yong VW
    J Neuroimmunol; 2005 Aug; 165(1-2):83-91. PubMed ID: 15958276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Minocycline on Extracellular Matrix Metalloproteinase Inducer, a Factor Implicated in Multiple Sclerosis Immunopathogenesis.
    Hahn JN; Kaushik DK; Mishra MK; Wang J; Silva C; Yong VW
    J Immunol; 2016 Nov; 197(10):3850-3860. PubMed ID: 27733550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic screening of generic drugs for progressive multiple sclerosis identifies clomipramine as a promising therapeutic.
    Faissner S; Mishra M; Kaushik DK; Wang J; Fan Y; Silva C; Rauw G; Metz L; Koch M; Yong VW
    Nat Commun; 2017 Dec; 8(1):1990. PubMed ID: 29259169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Hu X; Zou Y; Pi R; Liu M; Wang T; Zheng X; Liu M; Lin M; Liu P; Tao L
    J Neuroimmunol; 2009 May; 210(1-2):22-9. PubMed ID: 19344957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.
    Chen X; Pi R; Liu M; Ma X; Jiang Y; Liu Y; Mao X; Hu X
    J Neuroimmunol; 2010 Sep; 226(1-2):104-9. PubMed ID: 20538348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ageing and recurrent episodes of neuroinflammation promote progressive experimental autoimmune encephalomyelitis in Biozzi ABH mice.
    Peferoen LA; Breur M; van de Berg S; Peferoen-Baert R; Boddeke EH; van der Valk P; Pryce G; van Noort JM; Baker D; Amor S
    Immunology; 2016 Oct; 149(2):146-56. PubMed ID: 27388634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined treatment with atorvastatin and minocycline suppresses severity of EAE.
    Luccarini I; Ballerini C; Biagioli T; Biamonte F; Bellucci A; Rosi MC; Grossi C; Massacesi L; Casamenti F
    Exp Neurol; 2008 May; 211(1):214-26. PubMed ID: 18346732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.
    Koch MW; Zabad R; Giuliani F; Hader W; Lewkonia R; Metz L; Wee Yong V
    J Neurol Sci; 2015 Nov; 358(1-2):131-7. PubMed ID: 26344560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prospects of minocycline in multiple sclerosis.
    Chen X; Ma X; Jiang Y; Pi R; Liu Y; Ma L
    J Neuroimmunol; 2011 Jun; 235(1-2):1-8. PubMed ID: 21565409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minocycline effects on the cerebrospinal fluid proteome of experimental autoimmune encephalomyelitis rats.
    Stoop MP; Rosenling T; Attali A; Meesters RJ; Stingl C; Dekker LJ; van Aken H; Suidgeest E; Hintzen RQ; Tuinstra T; van Gool A; Luider TM; Bischoff R
    J Proteome Res; 2012 Aug; 11(8):4315-25. PubMed ID: 22768796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
    McLaughlin PJ; McHugh DP; Magister MJ; Zagon IS
    BMC Immunol; 2015 Apr; 16():24. PubMed ID: 25906771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible neural stem cell niche dysfunction in a model of multiple sclerosis.
    Rasmussen S; Imitola J; Ayuso-Sacido A; Wang Y; Starossom SC; Kivisäkk P; Zhu B; Meyer M; Bronson RT; Garcia-Verdugo JM; Khoury SJ
    Ann Neurol; 2011 May; 69(5):878-91. PubMed ID: 21391234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Siponimod (BAF312) prevents synaptic neurodegeneration in experimental multiple sclerosis.
    Gentile A; Musella A; Bullitta S; Fresegna D; De Vito F; Fantozzi R; Piras E; Gargano F; Borsellino G; Battistini L; Schubart A; Mandolesi G; Centonze D
    J Neuroinflammation; 2016 Aug; 13(1):207. PubMed ID: 27566665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lanthionine ketimine ester provides benefit in a mouse model of multiple sclerosis.
    Dupree JL; Polak PE; Hensley K; Pelligrino D; Feinstein DL
    J Neurochem; 2015 Jul; 134(2):302-14. PubMed ID: 25846048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis.
    Brundula V; Rewcastle NB; Metz LM; Bernard CC; Yong VW
    Brain; 2002 Jun; 125(Pt 6):1297-308. PubMed ID: 12023318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pentraxin-3 is upregulated in the central nervous system during MS and EAE, but does not modulate experimental neurological disease.
    Ummenthum K; Peferoen LA; Finardi A; Baker D; Pryce G; Mantovani A; Bsibsi M; Bottazzi B; Peferoen-Baert R; van der Valk P; Garlanda C; Kipp M; Furlan R; van Noort JM; Amor S
    Eur J Immunol; 2016 Mar; 46(3):701-11. PubMed ID: 26576501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive effect of the combination of glatiramer acetate and minocycline in a model of MS.
    Giuliani F; Metz LM; Wilson T; Fan Y; Bar-Or A; Yong VW
    J Neuroimmunol; 2005 Jan; 158(1-2):213-21. PubMed ID: 15589056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice.
    Smith PA; Morris-Downes M; Heijmans N; Pryce G; Arter E; O'Neill JK; 't Hart B; Baker D; Amor S
    J Neuroimmunol; 2005 Jul; 164(1-2):76-84. PubMed ID: 15927270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.